PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS
Disclosed are compounds of Formula (I):or a salt thereof, wherein R1, R2, R4, R6, m, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 14. Feb. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
CHEN YAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-14, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 |
---|
Patentnummer: |
EP4320112 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA019228872 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA019228872 | ||
003 | DE-627 | ||
005 | 20240308101046.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240301s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA019228872 | ||
035 | |a (EPA)EP4320112 | ||
035 | |a (EPA)81385129 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a CHEN YAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-14, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 | ||
520 | |a Disclosed are compounds of Formula (I):or a salt thereof, wherein R1, R2, R4, R6, m, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a KUMI GODWIN KWAME |4 aut | |
700 | 0 | |a HUANG AUDRIS |4 aut | |
700 | 0 | |a NAIR SATHEESH KESAVAN |4 aut | |
700 | 0 | |a SHIMPUKADE BHARAT DINKAR |4 aut | |
700 | 0 | |a PENMETSA SURESH BABU VISHWA KRISHNA |4 aut | |
700 | 0 | |a BALOG JAMES AARON |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 14. Feb. |
773 | 1 | 8 | |g year:2024 |g day:14 |g month:02 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/81385129/publication/EP4320112A1?q=EP4320112 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 14 |c 02 |